About AIMA
AIMA is a Healthcare company based in Vancouver (Canada) founded in 2019 by Lanna Last, Mali Meibod, and Melanie Ter Borg. Cannabis-infused products for menstrual pain relief are provided. AIMA has raised $600.7 thousand across 1 funding round from investors including IndieBio. The company has 5 employees. Its chief executive, as recorded, is Lanna Last. AIMA offers products and services including OVY RELIEFâ„¢ and CBD / CBG Vaginal Suppositories. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Women Health. Its legal entity is AIMA USA INC.
Company details
AIMA was founded in 2019 in Vancouver, Canada, as a provider of cannabis-infused products targeted at menstrual pain management. Operations are conducted in the health and wellness sector, where specialized formulations are developed and distributed to address period-related discomfort. The company is led by co-founders Lanna Last as CEO, Mali Meibod, and Melanie Ter Borg, with activities centered on product innovation and regulatory compliance in the Canadian market.
- Headquarters Vancouver, Canada
- Employees 5
- Founders Lanna Last, Mali Meibod, Melanie Ter Borg
- SectorsHealthcare
- Email••••••••
- Website my-aima.com
- Social LinkedIn X Facebook Instagram
- Legal Name Aima Usa Inc
- Total Equity Funding$600.7K (USD)
in 1 rounds
- Latest Funding Round$600.7K (USD), Seed
Dec 2022
- Investors
- Employee Count5
Products & Services of AIMA
AIMA offers a comprehensive portfolio of products and services, including OVY RELIEF™ and CBD / CBG Vaginal Suppositories.
CBD and CBG suppository for relieving menstrual pain and symptoms.
Suppositories designed to manage pelvic pain during menstruation.
Funding Insights of AIMA
AIMA has successfully raised a total of $600.7K through 1 strategic funding round. The most recent funding activity was a Seed round of $600.7 thousand completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $600,700
- Total Rounds 1
- Last Round Seed — $600,700
- First Round $600,700
(Dec 2022)
- Investors Count 1
All 1 funding rounds of AIMA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $600,700 | Seed | – | IndieBio | – |
1 investors in total: 1 institutional.
Investors in AIMA
AIMA has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States |
Investor details for AIMA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AIMA
3 people are tracked at AIMA (3 in leadership); the tracked headcount is 5.
| Name | Role | Group |
|---|---|---|
Lanna Last | Co-Founder & CEO | Leadership |
Mali Meibod | Co-Founder | Leadership |
Melanie Ter Borg | Co-Founder | Leadership |
Complete people profiles for AIMA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AIMA
2 dated milestones of AIMA across 3 years, from founding to its latest funding, stage changes and deals.
- Founded AIMA is founded.
- Funding First funding round of $601K.
Web traffic of AIMA
The website of AIMA (my-aima.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 44.1% vs previous month
Top companies in Cannabis Health Tech Ecosystem
2 companies that operate in the same segment as AIMA (Cannabis Health Tech Ecosystem) in Canada, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | USD 204.24 M | 960 | ||
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | USD 186.16 M | 898 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AIMA
AIMA was founded in 2019 and raised its 1st funding round 3 years after it was founded.
AIMA is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Lanna Last is the CEO of AIMA, as recorded in our data. They have also founded this company.
AIMA is a funded company, having raised a total of $600.7K across 1 funding round to date. The company's 1st funding round was a Seed of $600.7K, raised on Dec 2022.
AIMA has 5 employees.
AIMA was founded in 2019 in Vancouver, Canada, as a provider of cannabis-infused products targeted at menstrual pain management. Operations are conducted in the health and wellness sector, where specialized formulations are developed and distributed to address period-related discomfort. The company is led by co-founders Lanna Last as CEO, Mali Meibod, and Melanie Ter Borg, with activities centered on product innovation and regulatory compliance in the Canadian market.
AIMA offers OVY RELIEFâ„¢ and CBD / CBG Vaginal Suppositories.
AIMA has 1 investor. Key investors include IndieBio.
AIMA operates through Aima Usa Inc.